quantitative
Analysis v1
39
0
Taking oral semaglutide for 6 months helped lower blood sugar levels in 32 people with type 2 diabetes, reducing their HbA1c by about 9% on average.
Scientific Claim
In 32 adults with type 2 diabetes, oral semaglutide use over 26 weeks was associated with a 9.1% reduction in HbA1c (from 46.1 mmol/mol to 41.9 mmol/mol).
Original Statement
“Improvements in both parameters were already evident at T3 compared with baseline, with further improvements at T6 compared to T3.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study is observational with no control group, so causation cannot be established. The use of 'associated with' correctly reflects the evidence.
Evidence from Studies
Supporting (1)
39
Contradicting (0)
0
No contradicting evidence found